Zenotech Laboratories Intrinsic Value
Zenotech Laboratories (ZENOTECH) median intrinsic value is ₹17.70 from 4 valuation models (range ₹13–₹31), vs current price ₹44.24 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. See ZENOTECH book value to compare market price against book value per share.
ZENOTECH Valuation Methods Summary — DCF, Graham Number & P/E
Zenotech Laboratories intrinsic value across 4 models vs current price ₹44.24 — upside/downside and value range per method. For current market price and key ratios, visit ZENOTECH stock price BSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹31.15 | ₹28.04 - ₹34.27 | -29.6% | Book Value/Share: ₹15.57, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹13.27 | ₹11.94 - ₹14.60 | -70.0% | Revenue/Share: ₹3.93, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹17.70 | ₹15.93 - ₹19.47 | -60.0% | EBITDA: ₹8.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹17.70 | ₹14.16 - ₹21.24 | -60.0% | CF Growth: 5.0%, Discount: 15% |
ZENOTECH Intrinsic Value vs Market Price — All Valuation Models
Zenotech Laboratories fair value range ₹13–₹31 vs current market price ₹44.24 across 4 valuation models. Check Zenotech Laboratories marketcap in USD to track the company's total market size over time.
ZENOTECH Intrinsic Value Analysis — Undervalued or Overvalued?
Zenotech Laboratories median intrinsic value ₹17.70, current price ₹44.24 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of ZENOTECH?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Zenotech Laboratories (ZENOTECH) is ₹17.70 (median value). With the current market price of ₹44.24, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹13.27 to ₹31.15, indicating ₹13.27 - ₹31.15.
Is ZENOTECH undervalued or overvalued?
Based on our multi-method analysis, Zenotech Laboratories (ZENOTECH) appears to be trading above calculated value by approximately 60.0%.
ZENOTECH Financial Health — Key Ratios vs Industry Benchmarks
Zenotech Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 10.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 24.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.22x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ZENOTECH Cash Flow Quality — Operating & Free Cash Flow
Zenotech Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹10 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹10 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹12 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹21 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹18 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |